<!DOCTYPE html>
<html lang="en"><!-- InstanceBegin template="/Templates/page_layout.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<meta charset="utf-8" />

<!-- InstanceBeginEditable name="doctitle" -->

<title>VCU Office of Research and Innovation - Technology: “Human Imatinib Mesylate-Resistant Leukemia Cell Lines”</title>

<!-- InstanceEndEditable -->

<meta name="viewport" content="width=device-width, initial-scale=1.0" /><!--iPhone image scaling fix-->

<link href="../../css/page_layout.css" rel="stylesheet" type="text/css" media="all"/>
<link href="../../css/media_queries.css" rel="stylesheet" type="text/css" media="all"/>
<link rel="stylesheet" href="../../css/print.css" type="text/css" media="print" />
<link href='http://fonts.googleapis.com/css?family=Enriqueta:400,700' rel='stylesheet' type='text/css'>

<link REL="SHORTCUT ICON" HREF="http://www.research.vcu.edu/favicon.ico"> <!--icon in the address bar...do NOT delete-->
   
<script type="text/javascript" src="http://www.research.vcu.edu/js/respond.js"></script>

<!--[if IE 6]>
	<link a href="http://www.research.vcu.edu/css/IE_fixes/IE6.css" rel="stylesheet" type="text/css" media="all"/>
	<script type="text/javascript" src="http://www.research.vcu.edu/js/iehoverfix.js"></script>
<![endif]-->

<!--[if IE 7]>
	<link a href="http://www.research.vcu.edu/css/IE_fixes/IE7.css" rel="stylesheet" type="text/css" media="all"/>
	<script type="text/javascript" src="http://www.research.vcu.edu/js/iehoverfix.js"></script>
<![endif]-->

<!-- InstanceBeginEditable name="head" -->

<style>

#top_nav #nav_tech a {
		color:#fff;
		border-left:3px solid #fff;
		border-right:3px solid #fff;
	}

h2 {
	text-align:center;
	padding-top:1em;
}

</style>

<!-- InstanceEndEditable -->

</head>

<body>

<div id="page">
	<div id="header">
    	<div id="logo_bar">
        	<a href="http://www.vcu.edu" target="_blank"><img src="../../images/identity_header/branding_bar.png" alt="VCU bar logo" id="vcu_logo_desktop" /></a>
            <a href="http://www.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/vcuseal.gif" alt="VCU logo" id="vcu_logo_mobile" /></a>
       	</div>
        <span id="skip_link"><a href="#mainContent">skip to main content</a></span>
        <div id="identity_search">
        	<div id="vcu_research">
            	<a href="../../index.htm"><img src="../../images/identity_header/office_research.png" alt="Office of Research and Innovation" id="office_research" /></a>
        	</div><!--end vcu_research-->
			<div id="search">
  				<form action="http://search.vcu.edu/search" method="get">
  				<input type="text" name="q" id="searchField" placeholder="Search" />
                <input type="hidden" name="query" value="">
              	<input type="hidden" name="proxystylesheet" value="research">
          		<input type="hidden" name="output" value="xml_no_dtd">
               	<input type="hidden" name="client" value="research"> 
              	<input type="hidden" name="sort" value="date:D:L:d1">
               	<input type="hidden" name="entqr" value="3">
              	<input type="hidden" name="oe" value="UTF-8">
               	<input type="hidden" name="ie" value="UTF-8">
               	<input type="hidden" name="ud" value="1">
                <input type="hidden" name="site" value="research-main">
  				<label for="searchField">Search for:</label>
  				<button class="search_btn" type="submit"></button>
</form>
           	</div>
  		</div><!--end identity_search-->
  
<div id="top_nav_container">
<div id="top_nav">
	<ul>
		<li id="nav_prop_awards"><a href="../../osp/index.htm">Proposals &amp; Awards</a></li>
		<li id="nav_human"><a href="../../human_research/index.htm">Human Research</a></li>
        <li id="nav_animal"><a href="https://www.vcu.edu/research/acup/index.htm">Animal Research</a></li>
        <li id="nav_tech"><a href="../index.htm">Innovation</a></li>
        <li id="nav_conduct"><a href="../../research_conduct/index.htm">Researcher Conduct</a></li>
	</ul>
</div>
</div> <!-- end top_nav_container -->
</div><!--end header-->
<div id="main">
	<div id="page_head">            
            <div id="heading_bar">
				<!-- InstanceBeginEditable name="heading bar" -->            	
                <h1>VCU Innovation Gateway</h1>
				<!-- InstanceEndEditable -->     	
            </div><!--end heading_bar-->
            
            <div id="head_image">
		    <!-- InstanceBeginEditable name="head image" -->            	
                <img src="../../images/head_images/ott.jpg" alt="image of the word innovation in the dictionary" />
                <!-- InstanceEndEditable -->            
          	</div><!--end head image-->
    	</div><!--end page_head-->
	<div id="content">       
      <div id="content_text">
      <a id="mainContent"></a>
<!-- InstanceBeginEditable name="content" -->

<p id="breadcrumbs"><a href="../index.htm">VCU Innovation Gateway</a> &raquo; <a href="../technologies_index.htm">Technologies Available for Licensing</a></p>

<h2>"Human Imatinib Mesylate-Resistant Leukemia Cell Lines"<span id="tech_number">VCU #11-056</span></h2>

	<div id="sidebar">
    	<div id="app_advant">
        	<p class="style1">Applications</p>
            	<ul>
                	<li><em>In vitro</em> and <em>in vivo</em> studies on Acute Lymphoblastic Leukemia (ALL)</li>
                    <li><em>In vitro</em> and <em>in vivo</em> studies on Chronic Myelogenous Leukemia (CML)</li>
                    <li>Research tool</li>
              	</ul>
           	
            <p class="style1">Advantages</p>
            	<ul>
                	<li>First human cell line completely resistant to imatinib</li>
                    <li>Suitable for <em>in vivo</em> studies in immunocompromised mice</li>
                    <li>Resistance levels remain stable in cultures without imatinib</li>
                    <li>Potential to create resistant cell lines with other mutations</li>
               	</ul>
        </div>
        
        <div id="inv_contact">
        	<p class="style1">Inventors</p>
            	<ul class="list_no_bullets">
                	<li><a href="http://www.massey.vcu.edu/massey-member-directory-2011.aspx?id=75" target="_blank">Steven Grant, MD</a></li>
                    <li>Tri Nguyen, Ph.D.</li>
               	</ul>
          	
            <p class="style1">Contact</p>
            	<ul class="list_no_bullets">
                	<li><strong>T. Allen Morris, Ph.D., MBA</strong></li>
                    <li>Associate Director</li>
                    <li><a href="mailto:amorris5@vcu.edu">amorris5@vcu.edu</a></li>
                    <li>(804) 827-2211</li>
               	</ul>
          	<a href="pdf/GRA-11-56.pdf" target="_blank">Click here for PDF Version</a>
        </div>
  	</div>

  <p class="licensable_tech">Market Needs</p>

  <p>Imatinib mesylate (Gleevec®) is currently the first line therapy for   newly diagnosed Chronic Myelogenous Leukemia (CML) and Acute   Lymphoblastic Leukemia (Ph+ ALL). However acquired resistance of cells   to imatinib mesylate represents a significant clinical problem, in   particular, mutations in the kinase domain of Bcr/Abl, which prevent   drug binding and inhibitory activity, have been identified as the   leading cause of resistance. This mutation has increasingly become the   focus of research on CML and ALL, but currently there are no   immortalized human leukemia (or other) cell line expressing the Bcr/Abl   E255K mutation. All available cells of murine origin do not precisely   recapitulate either the genetics or biology of human ALL or CML cells,   and are therefore not ideal for such research.</p>

  <p class="licensable_tech">Technology  Summary</p>
  
  <img src="images/GRA-11-56.png" alt="bar chart complementing technology" style="float:right; margin:1em" />
  
  <p>By altering a commonly used in <em>in vitro</em> studies human ALL cell   line, named BV173, Dr. Grant and colleagues have generated an imatinib   resistant cell line that contains the most frequently observed mutation   (E255K) responsible for the drug resistance (see figure). This cell line   is a unique resource in developing strategies capable of circumventing a   clinically relevant and important form of the resistance to imatinib   mesylate and potentially other tyrosine kinase (Bcr/Abl) inhibitors. In   addition, it has been shown that this line is suitable for <em>in vivo</em> studies in immunocompromised mice, which adds to its value.</p>

<p class="licensable_tech">Technology Status</p>

  <p><em>In vitro</em> and <em>in vivo</em> data available. For more information visit: <a href="http://www.ncbi.nlm.nih.gov/pubmed/21474579" target="_blank">Clin Cancer Res</a>. 2011 May 15;17(10):3219-32. doi: 10.1158/1078-0432.CCR-11-0234. Epub 2011 Apr 7.</p>
  
  <p>This technology is available for licensing to industry for use in medical research.</p>
  
  <!-- InstanceEndEditable -->
      </div><!--end content_text-->
    </div><!--end content-->    
    <div id="right_nav">
    
    	<div class="nav_heading">VP for Research and Innovation &#187;</div>
        	<ul>
        		<li><a href="../../vpr/index.htm">VP for Research and Innovation</a></li>
                <li><a href="../../centers_cores/institutes.htm">Institutes and Centers</a></li>
                <li><a href="../../centers_cores/core_laboratories.htm">Research Cores</a></li>
                <li><a href="../../vpr/research_fund/index.htm">Research Quest Fund</a></li>
                <li><a href="../../vpr/grant_writing/index.htm">Grant Writing Institute</a></li>
                <li><a href="../../research_development/index.htm">Research Development</a></li>
                <li><a href="../../ugresources/index.htm">Undergraduate Research</a></li>
        		<li><a href="../../postdoc/index.htm">Postdoctoral Services</a></li>               
        	</ul>
            
    	<div class="nav_heading">Research Quick Links &#187;</div>
        	<ul>                               
                                
                <li><a href="../../vpr/research_compliance.htm">Research Compliance Matrix</a></li>
                <li><a href="../../vcuera/index.htm">VCUeRA</a></li>
                <li><a href="../../forms/index.htm">Forms</a></li>
                <li><a href="../../events/index.htm">Events</a></li>
                <li><a href="../../policies/index.htm">Policies</a></li>                
                <li><a href="../../vpr/contactus.htm">Contact a Specific Office</a></li>
                <li><a href="http://www.adobe.com/products/acrobat/readstep2.html" target="_blank">Download Adobe Reader</a><!-- #BeginLibraryItem "/Library/pdf_logo.lbi" --><img src="../../graphics/pdf_logo.gif" alt="pdf logo" style="margin-bottom:-.25em;" /><!-- #EndLibraryItem --></li>
        	</ul>
        
     	<div id="helpline">
       	  <a href="http://www.assurance.vcu.edu/reporting.html" target="_blank"><img src="../../images/helpline.jpg" alt="Helpline Image: To report any concern or for more information, (888)242-6022; www.vcuhelpline.com; www.ethicspoint.com" /></a>   	    
        </div>
       	</div><!--end right_nav-->    
    
   <div id="signature">
  		<ul>
    		<li><a href="http://www.vcu.edu" target="_blank">Virginia Commonwealth University</a> | <a href="http://www.research.vcu.edu/" target="_blank">Office of Research and Innovation</a></li>
            <li>800 East Leigh Street  PO Box 980568 Richmond, VA 23298</li>
            <li><a href="mailto:erahelp@vcu.edu?subject=Website%20Comments" target="_blank">Contact Us</a> | Updated: <!-- #BeginDate format:Am3 -->08/13/2014<!-- #EndDate --> | <a href="../../sitemap.htm">Site Map</a> | <a href="http://ts.vcu.edu/cgi-bin/posh.pl">View text-only version</a></li>
     	</ul>
</div><!--end #signature-->

</div><!--end main-->

<div id="vcu_footer">

	<a href="http://www.makeitreal.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/makeitrealFooter.gif" alt="Make It Real" /></a>
    
    <a href="http://www.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/vcubar-footer.gif" alt="Virginia Commonwealth University" /></a>
    
</div>
	
</div><!--end .page-->
</body>
<!-- InstanceEnd --></html>
